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Introduction {#sec1}
============

The ability to repair DNA damage is critically important for the preservation of genomic integrity. DNA double-strand breaks (DSBs) can be repaired by two different cellular pathways: homologous recombination (HR) and nonhomologous end-joining (NHEJ) ([@bib19]). HR processes use undamaged homologous DNA sequences---typically from the sister chromatid---as a repair template, thus enabling error-free repair. NHEJ can also restore chromosome integrity by religation of DSB ends ([@bib4]) in the absence of homologous sequences but is potentially more error prone. While core factors such as Ku, XRCC4, XRCC4-like Factor (XLF), and DNA ligase 4 are required for all NHEJ repair reactions, accessory factors, including polymerases and nucleases, are also needed to process termini of imprecise DSBs into ligatable substrates.

The relative preference for break repair pathways differs between eukaryotes. Mammalian cells use NHEJ as the predominant DSB repair mechanism, where the pathway is available throughout the cell cycle. Yeast prefer to repair DSBs by HR ([@bib16]). Nevertheless, most eukaryotes utilize both NHEJ and HR; therefore, the choice of repair pathway is crucial for cell survival. DSB repair pathway selection is regulated in the cell cycle, with NHEJ predominating in G~1~ phase and HR restricted to the G~2~ and S phases of the cell cycle ([@bib8]). Cyclin-dependent kinase 1 (Cdk1) plays a key role in regulating end resection during HR. Resection is strongly inhibited by low Cdk1 activity in G~1~ and can be reduced in G~2~ by Cdk1 inhibition ([@bib2; @bib12]). In mammalian cells and budding yeast, the main target of CDK phosphorylation is CtIP/Sae2, which facilitates DSB end resection ([@bib11]). Cdk1 phosphorylation also influences later steps in HR, as well as expression levels of HR proteins.

In budding yeast, the initiation of DSB resection is normally suppressed in G~1~ due to low Cdk1 activity and depends on the MRX complex ([@bib5]). However, this dependence on Cdk1 activity can be overcome by deletion of Ku, suggesting that it induces indirect control over NHEJ by affecting HR instead. Several potential Cdk1 phosphorylation sites have been found in budding yeast Ku70/Ku80; however, their mutation did not affect NHEJ activity ([@bib22]). Thus, direct Cdk1 targets for NHEJ regulation have not yet been identified. In fission yeast, there is a reciprocal relationship between the deployment of the two major DSB pathways with NHEJ functioning during G~1~ and HR predominant in G~2~ cells ([@bib7]). It has been proposed that Cdk1 may influence this pathway selection, but a mechanism has not been identified.

Xlf1 is the fission yeast homolog of XLF/Cernunnos ([@bib10; @bib3]), a core NHEJ factor that binds to DNA and stimulates end-joining. In the present study, we identify Xlf1 as a key regulator of NHEJ activity in the cell cycle. We report that Cdk1 phosphorylates specific residues in the C terminus of Xlf1 over the course of the cell cycle. Using phospho-null and phosphomimic mutant strains, we demonstrate that Xlf1 phosphorylation inhibits the NHEJ pathway. We also identify effects on the checkpoint response and cellular events related to DSB resection. Together, these data establish that Xlf1 phosphorylation by Cdc2^Cdk1^ provides a molecular mechanism for the downregulation of NHEJ in fission yeast and offers insights into how this pathway may be regulated in other eukaryotic organisms.

Results and Discussion {#sec2}
======================

Cdk1 Phosphorylates Xlf1 In Vitro {#sec2.1}
---------------------------------

NHEJ is tightly regulated in fission yeast, but the mechanism is unknown ([@bib7]). To identify if posttranslational modifications regulate NHEJ in *S. pombe*, we analyzed the sequences of the core factors (Ku, Lig4, and Xlf1). The C-terminal region of Xlf1 has two sites, T180 and S192, that conform to \[ST\]-P-x-\[KR\], a consensus motif for phosphorylation by the Cdc2^Cdk1^ kinase. These potential phosphorylation sites are conserved in other fission yeasts ([Figure 1](#fig1){ref-type="fig"}A). To test if these sites serve as substrates for Cdc2^Cdk1^, we mutated them to alanine and performed kinase assays. Wild-type (WT) and mutated Xlf1 proteins were incubated with mammalian Cdk1 kinase ([Figure 1](#fig1){ref-type="fig"}B) or *S. pombe* Cdc2^Cdk1^ complex ([Figure 1](#fig1){ref-type="fig"}C). Similarly to histone H1, a known Cdc2^Cdk1^ substrate ([@bib18]), Xlf1 was phosphorylated, establishing it as an in vitro substrate for the mammalian and the fission yeast kinase. Phosphorylation of single point mutants (Xlf1.T180A or Xlf1.S192A) was markedly reduced compared to WT Xlf1, suggesting that the two sites can be phosphorylated. When both residues were mutated to alanine (Xlf1.T180A.S192A or Xlf1.AA), Xlf1 phosphorylation was abolished. Thus, Cdc2^Cdk1^ can phosphorylate Xlf1 on two conserved C-terminal residues in vitro.

Xlf1 Is Phosphorylated by Cdk1 in a Cell-Cycle-Dependent Manner {#sec2.2}
---------------------------------------------------------------

Next, we sought to investigate if phosphorylation of Xlf1 occurs in vivo. While phosphorylation had no apparent effect on the migration of Xlf1 in standard SDS-PAGE ([Figures 1](#fig1){ref-type="fig"}B and 1E), addition of a phosphate-binding agent, Phos-tag ([@bib14]), resolved phosphorylated Xlf1 as a distinct band. GFP-tagged Xlf1 was immunoprecipitated from asynchronous cultures and analyzed by Phos-tag western blotting. The slower migrating species was abolished by treatment with lambda phosphatase ([Figure 1](#fig1){ref-type="fig"}D), confirming that this represented phosphorylated cellular Xlf1. This species was absent in *xlf1.AA*, a strain that expresses Xlf1.AA, regardless of treatment with phosphatase. Together, these results demonstrate that Xlf1 is phosphorylated at T180 and S192 in vivo and indicate that further Cdc2^Cdk1^ kinase sites are unlikely.

To determine if Cdc2^Cdk1^ is responsible for Xlf1 phosphorylation in vivo, we used a *cdc2-as* mutant strain in which we could inhibit Cdc2^Cdk1^ activity ([@bib6]). Treatment of *cdc2as GFP-xlf1* cultures with the inhibitor (1NM-PP1) caused a significant reduction of the phosphoband of Xlf1 in Phos-tag western blots, which could be further reduced by phosphatase treatment ([Figure 1](#fig1){ref-type="fig"}E). This establishes that Xlf1 is phosphorylated by Cdc2^Cdk1^ in unperturbed asynchronous cultures.

Cdc2^Cdk1^ activity increases from a minimum in G~1~ to levels peaking in G~2~, triggering entry into mitosis. To study changes in Xlf1 phosphorylation status as cells progressed through the cell cycle, we used a temperature-sensitive *cdc10* mutant (*cdc10-M17*) to synchronize GFP-*xlf1* cultures in G~1~. A phospho-Xlf1 species was not detectable in G~1~-arrested cells ([Figure 1](#fig1){ref-type="fig"}F); however, upon release from the arrest, phosphorylated Xlf1 appeared and increased after 120 min, as cells entered G~2~ phase. These data indicate that Cdc2^Cdk1^ phosphorylates Xlf1 in a cell-cycle-dependent manner.

Xlf1 Phosphorylation by Cdc2^Cdk1^ Alters the Repair of DSBs by NHEJ {#sec2.3}
--------------------------------------------------------------------

As NHEJ is most active in G~1~ but inhibited in S/G~2~ ([@bib7]), we predicted that Xlf1 phosphorylation inhibits NHEJ. To test this hypothesis, we examined the ability of *xlf1* phosphorylation mutants to religate linearized plasmid DNA ([@bib16]). Leucine auxotrophic cells were transformed with linearized plasmid DNA containing the *LEU2* marker. Their ability to religate ends and form colonies on selective plates lacking leucine was assessed by comparison to cells transformed with uncut plasmid. Log-phase cultures in which Cdc2^Cdk1^ phosphorylation of Xlf1 had been abolished (*xlf1.AA′*) displayed a ∼2.5-fold increase in end-joining compared to WT cells ([Figure 2](#fig2){ref-type="fig"}A). In contrast, the Xlf1 phosphomimetic mutant *xlf1.EE* showed a moderate decrease in plasmid end-joining. The religation levels were unaffected by the nature of the ends (blunt or overhangs) in *xlf1* mutants. These results indicated that an inability to phosphorylate Xlf1 leads to increased NHEJ activity and supports the hypothesis that Cdc2^Cdk1^ phosphorylation of Xlf1 inhibits NHEJ.

The resection of DSBs is thought to make them unsuitable for end-joining. Therefore, we asked if we could increase levels of end-joining of linearized plasmids by impairing the resection of DNA ends. We repeated the plasmid religation assays in a strain lacking the resection gene *ctp1*^*+*^. Deleting *ctp1* had no effect on plasmid religation levels ([Figure 2](#fig2){ref-type="fig"}B), suggesting that preventing Ctp1-dependent resection did not channel plasmid DSBs into NHEJ. However, when *ctp1*^*+*^ was deleted in *xlf1.AA* cells, end-joining levels increased \>4-fold compared to WT levels, significantly above an ≈2-fold increase caused by *xlf1.AA* in the presence of functional Ctp1. This finding suggested that, in log-phase cells, Ctp1 and phosphorylated Xlf1 synergistically counteract end-joining of linearized plasmid DNA.

Xlf1.AA Slows Down Cellular Responses to DSBs {#sec2.4}
---------------------------------------------

Next, we characterized cellular response to ionizing radiation (IR)-induced DSBs in Xlf1 phospho-null strains. A key event in the cellular response to DNA damage is the activation of DNA damage checkpoints that arrest progress in the cell cycle to ensure that DSBs can be repaired. We monitored the phosphorylation status of Chk1 kinase, a marker of G~2~ checkpoint activation ([@bib21]), in response to IR. IR-induced Chk1 phosphorylation was observed in *nmt41-xlf1.AA chk1-HA* cultures at all IR doses, with no discernible difference to WT *chk1-HA* cultures ([Figure 2](#fig2){ref-type="fig"}C). We also characterized the kinetics of the checkpoint response. In *chk1-HA* cells, Chk1 phosphorylation reached a maximum value within 10 min. In contrast, the phospho-Chk1 band did not appear until 10 min after irradiation, rising further at later time points. This observation suggests that nonphosphorylatable Xlf1 causes a deceleration of the checkpoint response, though full induction of the G~2~ checkpoint, as measured by Chk1 phosphorylation, is still achieved within 30 min.

Next, we studied the processing of IR-induced DSBs. Rad52 foci form after strand resection has begun and channeled into recombination processes ([@bib19]). In order to study the possible interference of phospho-null Xlf1 on such processes, we analyzed Rad52-GFP foci formed in live cells following IR. We irradiated *rad52-GFP* and *nmt41*-*xlf1.AA rad52-GFP* cells with 50 Gy and monitored the formation and persistence of Rad52-GFP foci using live-cell imaging. While Rad52 foci were observed in most cells with both WT *xlf1* and *nmt41*-*xlf1.AA*, foci formation was slower in *nmt41-xlf1.AA* ([Figure 2](#fig2){ref-type="fig"}D). Rad52 foci formation peaked ∼30 min after IR in WT cells but 40--70 min after IR in *nmt41*-xlf1.AA, in which Rad52 foci also persisted for longer. This observation is consistent with HR processes, including DSB resection, being slowed in *nmt41-xlf1.AA* cells. We did not observe a general decrease of Rad52 foci in *nmt41-xlf1.AA*. As Rad52 foci are associated with resection, and as resected DSBs are not a suitable substrate for NHEJ, the observed deceleration of HR is unlikely to be the result of the overall balance of DSB repair pathways being tipped in favor of NHEJ.

Overexpression of Xlf1.AA Sensitizes Cells to DNA Damage {#sec2.5}
--------------------------------------------------------

As the balance between HR and NHEJ is tightly regulated in the cell cycle, we next asked if deregulation of repair pathways resulted in altered sensitivity to DNA damage. To address this question, we characterized the IR sensitivity of Xlf1 phosphomutants in a stationary state, not requiring cell cycle regulation. Spores from homozygous crosses of *xlf1.AA* displayed an IR sensitivity similar to that of WT spores, in contrast to a small but reproducible increase in IR sensitivity with *xlf1.EE* spores ([Figure S1](#app2){ref-type="sec"}). This suggests that NHEJ is active but can be attenuated, as observed in the phosphomimetic *xlf1* mutant. Similarly, while deletion of *ctp1* increased IR sensitivity of spores, there was a small but reproducible increase in radioresistance in *xlf1.AA ctp1d*, whereas the opposite effect was evident with *xlf1.EE ctp1d* spores ([Figure S1](#app2){ref-type="sec"}). The IR sensitivity of *ctp1d* spores may be due to damage other than DSBs induced in the spore state, such as single-strand breaks and other lesions impeding the first round of replication following germination. Overexpression of WT *xlf1* and *xlf1.AA* from *nmt41* increased the IR resistance in spores above WT levels. This is again compatible with the notion that Xlf1 is a limiting factor regulating NHEJ levels.

In contrast to spores, mutation of the Xlf1 phosphorylation sites did not have a discernible effect on the sensitivity of vegetative cells to a range of DNA damage treatments (data not shown). However, overexpression using the medium-level *nmt41* promoter of Xlf1 in vegetative cells rendered *nmt41-xlf1.AA* cells mildly sensitive to a variety of DNA-damaging agents, such as camptothecin, *tert*-butyl hydroperoxide, phleomycin, and methyl methanesulfonate in comparison to *nmt1-xlf1* (WT) ([Figure S1](#app2){ref-type="sec"}). The sensitivity was increased in *nm41-xlf1.AA*. No increase in *xlf1.AA* DNA damage sensitivity was observed in strains in which *rad50* had been deleted ([Figure S1](#app2){ref-type="sec"}), revealing an epistatic relationship with *rad50*. In addition, we noted that high-level overexpression from the *nmt1* promoter of *xlf1.AA*, but not with WT *xlf1*, caused cells to become inviable ([Figures S1](#app2){ref-type="sec"} and [S2](#app2){ref-type="sec"}).

NHEJ Is Hyperactivated in an Xlf1 Cdk1 Phosphorylation Null Mutant {#sec2.6}
------------------------------------------------------------------

As plasmid religation assays have relaxed requirements for NHEJ ([@bib1]), we sought another in vivo assay to study the role of Xlf1 phosphorylation by Cdc2^Cdk1^ on chromosomal DSBs. Chromosome end fusions can be generated by NHEJ in cells with unprotected telomeres, such as *taz1d* ([@bib7]). However, chromosome end fusions are only generated if *taz1d* cells are arrested in G~1~ but not during S/G~2~, because of the downregulation of NHEJ activity in S/G~2~ phases. If cell cycle inhibition of NHEJ activity restricts *taz1d* chromosome fusions to G~1~ phase, disinhibition of NHEJ should lead to chromosome fusions in S/G~2~-phase *taz1d* cells. Therefore, *taz1d* strains provide a suitable assay to study the potential inhibitory effect of Xlf1 phosphorylation on NHEJ in vivo. We first compared G~1~-arrested (nitrogen-starved) and S/G~2~ (log-phase) cultures in which telomeres were unprotected due to *taz1*^*+*^ deletion. Chromosome fusions were detected in *taz1d* cells in G~1~ but not in S/G~2~ cells ([Figure 3](#fig3){ref-type="fig"}A). In contrast, no fusions appeared in G~1~-arrested *taz1d xlf1d* cells, because of downregulation of NHEJ, as expected. Chromosome fusions were also observed in *taz1d xlf1.AA* cells when arrested in G~1~ phase, showing that mutation of the phosphorylation sites preserves the ability to carry out NHEJ. It is important to note, however, that fusions were not detected in *taz1d xlf1.AA* during S/G2 phases. Thus, contrary to our prediction, disinhibition of NHEJ by preventing Xlf1 phosphorylation is not sufficient to fuse unprotected chromosome ends in log-phase cultures.

NHEJ and HR are regulated independently in the fission yeast cell cycle, as inactivation of HR does not lead to increased use of NHEJ in G~2~ cells ([@bib7]). Conversely, we expected that abnormal activation of NHEJ in G~2~ cells will take place in the presence of activated HR, since the disinhibition of NHEJ alone in the *xlf1.AA* mutant would not affect HR activity. Therefore, we reasoned that competition for DSBs between NHEJ and HR is likely taking place in *taz1d xlf1.AA* cells, potentially masking the disinhibition of NHEJ, which may only become detectable once HR is inactivated. To test this hypothesis, we repeated the experiment in a background in which *ctp1* was deleted. Ctp1 is essential for the initiation of resection, targeting DSBs toward HR ([@bib15]). When the chromosome fusion assays were repeated, no chromosome fusions were detected in *ctp1d taz1d xlf1*^*+*^ during S/G~2~ phases ([Figure 3](#fig3){ref-type="fig"}B), establishing that inactivation of Ctp1-dependent resection alone is not sufficient to cause fusion of unprotected chromosome ends. Strikingly, inactivation of HR in *ctp1d taz1d xlf1.AA* cells led to substantial telomere fusions. We analyzed seven independent clones ([Figure S3](#app2){ref-type="sec"}A) and found that all contained intra- and/or interchromosomal end fusions, including clones with circular chromosomes (both termini of a chromosome are fused) during S/G~2~ phases, a striking effect of NHEJ activity as confirmed by its absence in the corresponding *lig4d* strain ([Figure S3](#app2){ref-type="sec"}B). This indicates that *xlf1.AA* prevents the inhibition of NHEJ in G~2~ cells when HR is inactivated. In contrast, no chromosome fusions were detected in the corresponding phosphomimicking *xlf1* mutant, *ctp1d taz1d xlf1.EE*. These observations support the hypothesis that Cdc2^Cdk1^ phosphorylation of Xlf1 switches off NHEJ during the cell cycle.

To further explore the nature of competition between HR and NHEJ when both DSB repair pathways are active in the *xlf1.AA* phospho-null mutant, we speculated that overexpression of *xlf1*^*+*^ may overcome the requirement to inactivate HR. We constructed *taz1d* strains in which *xlf1*^*+*^ is controlled by the medium-strength *nmt41* promoter integrated at the *xlf1*^*+*^ locus. Chromosome fusions could be detected in log-phase *nmt41*-*xlf1.AA taz1d* cells, even though HR was functional ([Figure 3](#fig3){ref-type="fig"}C). Overexpression of WT *xlf1*^*+*^ similarly caused telomere fusions in the presence of HR function, though to a lesser extent than in the phospho-null mutant. This suggests that *xlf1*^*+*^ overexpression contributes to overcoming recombinogenic mechanisms that prevent chromosome fusions, tipping the HR/NHEJ balance in favor of end-joining, either by promoting NHEJ before DSB becomes subject to HR or by separately inhibiting HR. These observations imply that *xlf1* is an important regulator in the balance of HR versus NHEJ during the cell cycle.

Xlf1.AA Affects Both HR and NHEJ of Linearized Plasmid DNA {#sec2.7}
----------------------------------------------------------

The observation that chromosome end ligations (*taz1d* cells) in the *xlf1.AA* phosphomutant require inactivation of HR indicates crosstalk between NHEJ and HR. To verify if a similar effect could be identified in the processing of plasmid DNA ends by the two DSB repair pathways, we designed an assay in which the levels of HR and NHEJ can be assessed in parallel. Cells were electroporated with two different linearized plasmids. One plasmid, containing WT *leu1*^*+*^ but no ARS, could be integrated at the *leu1-32* locus via an HR-dependent mechanism, giving rise to Leu+ colonies. The second plasmid, containing the antibiotic resistance gene *hph*^*R*^ and an *S. pombe* ARS, could be recircularized by NHEJ and stably maintained, giving rise to hygromycin-resistant colonies. Hygromycin selection was applied after 2 hr. Cells were transformed in parallel; the frequency of leu1^+^ colonies and hygromycin-resistant colonies were determined in relation to an uncut plasmid control as a measure of HR and NHEJ activity, respectively. Deletion of *xlf1*^*+*^ decreased plasmid religation ∼50 fold ([Figure 3](#fig3){ref-type="fig"}D), whereas deletion of *ctp1*^*+*^ decreased plasmid integration ∼50 fold, indicative of inactivation of NHEJ and HR, respectively. Deletion of *xlf1*^*+*^ or *lig4*^*+*^ also caused a small but reproducible decrease in HR-dependent plasmid integration. Plasmid religation was increased in *xlf1.AA* mutant cells, though less than in the assay used in [Figure 3](#fig3){ref-type="fig"}D, presumably because of the much-reduced time available for religation with antibiotic rather than auxotrophic selection. Unexpectedly, plasmid integration was reduced by two-thirds in *xlf1.AA* (endogenous promoter), suggesting that disabling the phosphorylation of Xlf1 leads to inhibition of HR. In addition, while deletion of *ctp1*^*+*^ by itself had no significant impact on NHEJ, deletion of *ctp1*^*+*^ in an *xlf1.AA* mutant led to a much larger increase in plasmid religation than in HR-competent *xlf1.AA*. Together, these observations provide further evidence that phospho-null *xlf1.AA* affects the levels of HR.

Cell cycle regulation of DSB repair pathway selection by Cdk1 was first established with the discovery that DSB resection requires Cdk1 activity ([@bib2; @bib12]). However, while Cdk1 has been shown to control the function of several HR factors, a reciprocal regulation of NHEJ by Cdk1 has not been reported. While budding yeast Ku70 and Ku80 contain several potential Cdk1 phosphorylation sites, their mutation does not affect NHEJ activity ([@bib22]). Moreover, the dependence of resection for Cdk1 activity can be overcome by the deletion of Ku, suggesting an indirect control over NHEJ by modulation of HR ([@bib5]). Nej1, the budding yeast XLF homolog, was discovered as a factor downregulating NHEJ in diploid cells ([@bib9; @bib13; @bib20]). Lif1, the *S. cerevisiae* XRCC4 homolog, has been found to be phosphorylated by Cdk1, but this phosphorylation has little effect on the levels of classical NHEJ and, instead, affects a Sae2^ctp1^-dependent resection-mediated imprecise joining pathway ([@bib17]). Our study shows that Cdk1 phosphorylation of a core NHEJ factor directly regulates classical NHEJ during the cell cycle. We show that Xlf1 becomes phosphorylated by Cdc2^Cdk1^ on T180 and S192 and that the levels of phosphorylation increase through the cell cycle as Cdc2^Cdk1^ activity increases. These results establish that phosphorylation of Xlf1 has an inhibitory effect, as there is a reduction in the levels of religation of linearized DNA with the phosphomimic *xlf1.EE* but an increase with the phospho-null *xlf1.AA* mutant. Together, these observations allow us to propose a model in which Xlf1 functions as a cellular switch for NHEJ ([Figure 4](#fig4){ref-type="fig"}), with nonphosphorylated Xlf1 representing the on state (NHEJ active) and phosphorylated Xlf1 representing the off state (NHEJ inactive). The NHEJ repair pathway is fully active in G~1~, but as cells advance in the cell cycle, Cdc2^Cdk1^ levels rise and Xlf1 becomes increasingly phosphorylated, leading to inactivation of end-joining. Although this report establishes that Xlf1 is an important NHEJ regulator, further studies are required to establish how Cdk1 phosphorylation of this factor restrains NHEJ in cycling cells and whether this key regulatory function is also conserved in other eukaryotic organisms.

Experimental Procedures {#sec3}
=======================

Standard methods used for strain construction, western blotting, and microscopy are detailed in the [Supplemental Experimental Procedures](#app2){ref-type="sec"}. Strains used are listed in [Table S1](#app2){ref-type="sec"}.

Phosphatase Treatment of *nmt41*-GFP-Tagged Xlf1 {#sec3.1}
------------------------------------------------

A total of 10^9^ log-phase cells grown without thiamine was resuspended in lysis buffer (50 mM Na phosphate \[pH 7\], 150 mM NaCl, 50 mM NaF, 10 mM EDTA, 10% glycerol, 0.5% NP40, Roche protease inhibitor) and broken with glass beads. Cleared lysate containing 15 μg total protein was incubated for 2 hr at 4°C with 15 μl GFP-Trap A magnetic beads (Chromotek) per immunoprecipitation. Beads were washed with lysis buffer, washed three times in PMP buffer (New England Biolabs; NEB) plus MnCl~2~, resuspended in 100 μl, divided into two, and either mock treated or incubated with 800 units of lambda phosphatase (NEB) at 30°C for 30 min. Beads were resuspended in Laemmli buffer and boiled. Samples were separated by SDS-PAGE on 12% gels containing 25 μM Phos-tag (AAL-107 Wako) and 50 μM MnCl~2~. Prior to transfer onto polyvinylidene fluoride, gels were incubated for 10 min in transfer buffer with 1 mM EDTA and then without EDTA. GFP-Xlf1 was detected using anti-GFP antibody (Invitrogen, 1:2,500 dilution).

In Vitro Cdc2^Cdk1^ Kinase Assay {#sec3.2}
--------------------------------

Active Cdc2 enzyme was isolated from a lysate of 5 × 10^8^ WT *S. pombe* cells resuspended in 400 μl of HB buffer (25 mM Tris \[pH 7.5\], 15 mM EGTA, 15 mM MgCl~2~, 0.1% NP40, protease inhibitor cocktail) broken using glass beads. Per kinase reaction, cell lysate containing 1 mg total cellular protein was mixed with 40 μl of p13suc1 agarose conjugate (Millipore), incubated with rotation at 4°C for 3 hr, washed three times with HB buffer, and then washed once with kinase buffer (10 mM HEPES \[pH 7.5\], 75 mM KCl, 5 mM MgCl~2~, 1 mM dithiothreitol). For each kinase assay reaction, beads were then mixed in a total volume of 15 μl containing 1.5 μg purified protein (either recombinant 6His-Xlf1 or histone H1), 20 μM ATP, and 5μCi γ-^32^P-ATP, all diluted in kinase buffer. The same method was used with Cdk1 (NEB). The kinase reaction was allowed to proceed for 10 min at room temperature and then was stopped by adding SDS-PAGE loading buffer and heated to 90°C for 5 min. Protein was separated on 15% gels and subjected to Coomassie staining and autoradiography.

Author Contributions {#sec4}
====================
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![Xlf1 Is Phosphorylated by Cdk1\
(A) Alignment of the C-terminal portion of four fission yeast *xlf1* homologs (*S. pombe*, *S. octosporus*, *S. cryophilus*, and *S. japonicus*), displaying two conserved cdc2^cdk1^ phosphorylation motifs (yellow boxes): \[ST\]Px\[KR\].\
(B) In vitro Cdk1 kinase assay. Recombinant Xlf1 protein was incubated with mammalian Cdk1 in the presence of γ-^32^P-ATP and analyzed by autoradiography. Proteins used were the Cdk1 substrate histone H1 (positive control, 32 kDa), wild-type Xlf1 (27 kDa), single mutations of T180A and S192A, and double mutations T180A.S192A (AA). Recombinant Xlf1 is susceptible to cleavage between T180 and S192, and the cleavage product (indicated by an asterisk) is visible in the Coomassie-stained loading control.\
(C) In vitro kinase assay using *S. pombe* Cdc2. Kinase assay with recombinant protein was conducted as in (B), except using Cdc2 complex purified from *S. pombe* cells.\
(D) In vivo phosphorylation of Xlf1. GFP-tagged Xlf1 was immunoprecipitated from cell extracts of wild-type and *xlf1.T180A.S192A* (*xlf1.AA*), treated or mock treated with lambda phosphatase, and separated by SDS-PAGE in the presence of the phosphate-binding retardant Phos-tag. Phosphorylated Xlf1 is indicated by an arrow.\
(E) GFP-tagged wild-type Xlf1 was immunoprecipated from cells containing the Shokat active site mutation cdc2.F84G ([@bib6]) that had either been treated or mock treated with the inhibitor 1NM-PP1. Immunoprecipitates were treated or mock treated with lambda phosphatase and analyzed by SDS-PAGE and immunoblotting in either the presence or the absence of Phos-tag.\
(F) A temperature-sensitive mutation was used to block *cdc10-M17 nmt41-GFP.xlf1* cells in G~1~ phase and then released into the cell cycle. Phosphorylation of GFP-Xlf1 was analyzed by SDS-PAGE and immunoblotting of cell extracts in the presence or absence of Phos-tag. A nonspecific band detected by the GFP antibody is indicated by an asterisk.](gr1){#fig1}

![Phospho-Null *xlf1* Increases DNA End-Ligation Activity and Attenuates Damage Responses\
(A) Religation of linearized plasmids containing blunt ends, 3′ and 5′ overhangs. Leu+ selection used to monitor religated plasmids. Data are reported as the mean ± 95% confidence interval.\
(B) Religation of linearized plasmids with hygromycin selection within 2 hr of electroporation. Data are reported as the mean ± 95% confidence interval.\
(C) Chk1-HA phosphorylation in response to ionizing radiation was monitored in wild-type and *nmt41-xlf1.AA* cells. Cells irradiated with 50 Gy, 100 Gy, and 200 Gy were analyzed 30 min after irradiation. To characterize the kinetics of the checkpoint response, cells irradiated with 50 Gy were also analyzed at 3.5 min, 7 min, and 10 min after irradiation. Phosphorylated Chk1 is indicated.\
(D) The formation and persistence of Rad52-GFP foci following 50 Gy irradiation were monitored in wild-type and *nmt41*-*xlf1.AA* cells.](gr2){#fig2}

![*xlf1.AA* Promotes NHEJ Fusion of Unprotected Telomeres\
(A) Ligation of chromosome ends in *xlf1* mutants in *taz1d* strains. Scheme of telomeric NotI restriction fragments. Chromosomes I and II each release two telomeric restriction fragments (C, I, L, and M). Chromosome III lacks NotI restriction sites; NotI digests of genomic DNA of the indicated strains were separated by PFGE, and chromosomal end-to-end fusions were detected by Southern blotting with a telomere probe (arrows indicate positions of resolved telomere fusions). Nitrogen-starved *taz1d* used as positive control for fusions.\
(B) PFGE analysis reveals that Xlf1.AA promotes NHEJ-mediated telomeric fusions in cycling cells in *taz1d ctp1d* background.\
(C) Xlf1 overexpression is sufficient to promote telomeric fusions in *taz1d* cycling cells, and *xlf1.AA* mutation increases the amount of these fusions. Ligation of chromosome ends in *taz1d* strains overexpressing *xlf1* mutants from the *nmt41* promoter was analyzed by PFGE. *taz1*^+^ control strains contain the same amount of DNA, though the signal from the telomeric probe is weaker as a result of telomere elongation in *taz1d*.\
(D) Assaying for NHEJ and HR activities in parallel, using hygromycin resistance and leu1 integration of linearized plasmid fragments. Data are reported as the mean ± 95% confidence interval.\
See also [Figure S3](#app2){ref-type="sec"}C.](gr3){#fig3}

![Model of Cdk1 Regulation of the Balance between NHEJ and HR\
The activity of CDK1 is a major determinant of DSB repair pathway choice. When CDK1 is low, nonphosphorylated Xlf1 exists in the cell and NHEJ is fully active. As CDK1 activity rises, phosphorylation of Xlf1 increases, leading to the inactivation of NHEJ. The phosphorylation of CDK1 targets in the HR pathway leads to the activation of HR.](gr4){#fig4}
